Harrow (HROW) Non Operating Investment Income (2018 - 2024)

Harrow (HROW) recorded quarterly Non Operating Investment Income of -$1.9 million in Q2 2024, down 54.09% quarter-over-quarter from -$1.2 million in Q1 2024, and down 169.33% on a YoY basis from $2.8 million in Q3 2023.

Harrow (HROW) Non Operating Investment Income (2018 - 2024) Analysis & Trends

Harrow's Non Operating Investment Income history runs 7 years deep, the most recent figure standing at -$1.9 million for Q2 2024.

  • In Q2 2024, Non Operating Investment Income fell 169.33% year-over-year to -$1.9 million; the TTM figure through Dec 2024 stood at -$3.2 million (down 202.55% YoY), while the FY2024 annual figure was -$3.2 million, down 202.55% from the prior year.
  • Non Operating Investment Income was -$1.9 million for Q2 2024 at Harrow, down from -$1.2 million in the prior quarter.
  • In the past five years, Non Operating Investment Income ranged from a high of $2.0 million in Q1 2023 to a low of -$3.6 million in Q2 2021.
  • Historically, Non Operating Investment Income has averaged -$711666.7 across 5 years, with a median of -$735000.0 in 2020.
  • The sharpest annual moves came in 2021 and 2023: Non Operating Investment Income plunged 736.28% in 2021, then surged 1369.06% in 2023.
  • A 5-year view of Non Operating Investment Income shows it stood at $805000.0 in 2020, then sank by 284.72% to -$1.5 million in 2021, then jumped by 195.97% to $1.4 million in 2022, then tumbled by 70.85% to $416000.0 in 2023, then sank by 562.26% to -$1.9 million in 2024.
  • The last three Non Operating Investment Income figures came in at -$1.9 million (Q2 2024), -$1.2 million (Q1 2024), and $416000.0 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn -
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn -
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn -
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn -
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn -
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn -
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn -
10 Harrow 1.34 Bn 1.24 Bn 27.05 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2024 -1.92 Mn
Jun 30, 2024 -1.92 Mn
Mar 31, 2024 -1.25 Mn
Mar 31, 2024 -1.25 Mn
Dec 31, 2023 416,000.00
Dec 31, 2023 416,000.00
Sep 30, 2023 1.35 Mn
Sep 30, 2023 1.35 Mn
Jun 30, 2023 -714,000.00
Jun 30, 2023 -714,000.00
Mar 31, 2023 2.04 Mn
Mar 31, 2023 2.04 Mn
Dec 31, 2022 1.43 Mn
Dec 31, 2022 1.43 Mn
Sep 30, 2022 -1.03 Mn
Sep 30, 2022 -1.03 Mn
Jun 30, 2022 -3.45 Mn
Jun 30, 2022 -3.45 Mn
Mar 31, 2022 139,000.00
Mar 31, 2022 139,000.00